| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/18/2011 | WO2011047277A3 Release of agents from cells |
| 08/18/2011 | WO2011047051A3 Polymeric systems for the delivery of anticancer agents |
| 08/18/2011 | WO2011041680A3 Compositions and methods of prophylaxis for contact dermatitis |
| 08/18/2011 | WO2011037896A3 Polypeptide modification |
| 08/18/2011 | WO2011023367A3 Bisphosphonate-prodrugs |
| 08/18/2011 | WO2010123569A3 Immunonanotherapeutics providing a th1-biased response |
| 08/18/2011 | US20110201695 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsion |
| 08/18/2011 | US20110201654 Therapeutic combination |
| 08/18/2011 | US20110201586 Pharmaceutical composition and method for treating hypogonadism |
| 08/18/2011 | US20110201545 Gel based livestock feed, method of manufacture and use |
| 08/18/2011 | US20110201505 Mixtures comprising hydrolysis resistant organomodified disiloxane ionic surfactants |
| 08/18/2011 | US20110201115 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/18/2011 | US20110201052 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 08/18/2011 | US20110200695 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 08/18/2011 | US20110200680 Water insoluble polymer: starch-based film coatings for colon targeting |
| 08/18/2011 | US20110200665 Novel Thermosensitive Liposomes Containing Therapeutic Agents |
| 08/18/2011 | US20110200660 Poly(ester amide)-based drug delivery systems with controlled release rate and morphology |
| 08/18/2011 | US20110200582 Lipids, lipid compositions, and methods of using them |
| 08/18/2011 | US20110200555 Conjugates of hydroxyalkyl starch and a protein |
| 08/18/2011 | US20110200550 Multi-Arm Polymeric Alkanoate Conjugates |
| 08/18/2011 | US20110200538 Alternan Derivatives |
| 08/18/2011 | US20110200527 Peptide Ligand Directed Drug Delivery |
| 08/18/2011 | DE102004045186B4 Liposomen, die die intrazelluläre Penetration von Wirkstofen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of Wirkstofen, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration |
| 08/18/2011 | CA2827049A1 Dermatological pharmaceutical composition suitable for oligonucleotides |
| 08/18/2011 | CA2788834A1 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom |
| 08/18/2011 | CA2787990A1 Nucleic acid complexes |
| 08/18/2011 | CA2787718A1 Methods and compositions for the preparation of aerosols |
| 08/18/2011 | CA2786911A1 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute |
| 08/18/2011 | CA2786340A1 Igf-i poly (ethylene glycol) conjugates |
| 08/18/2011 | CA2785858A1 Particulate pharmaceutical composition |
| 08/17/2011 | EP2357202A1 Targeted binding agents directed to Upar and uses thereof |
| 08/17/2011 | EP2357187A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/17/2011 | EP2357009A1 Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections |
| 08/17/2011 | EP2357008A1 Albumin fusion proteins |
| 08/17/2011 | EP2357007A2 Liquid for discharge, method for discharging biospecimen, and compound |
| 08/17/2011 | EP2357006A2 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 08/17/2011 | EP2356996A1 Treatment for Alzeimer's disease |
| 08/17/2011 | EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof |
| 08/17/2011 | EP2356982A2 Antimicrobial compositions and methods |
| 08/17/2011 | EP2356167A2 Polyesters with grafted zwitterions |
| 08/17/2011 | EP2355853A1 Biodegradable polymer - bioactive moiety conjugates |
| 08/17/2011 | EP2355852A1 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 08/17/2011 | EP2355851A1 Novel lipids and compositions for the delivery of therapeutics |
| 08/17/2011 | EP2355805A1 Rifaximin complexes |
| 08/17/2011 | EP2355803A1 Organogel compositions and processes for producing |
| 08/17/2011 | EP2355795A2 Biodegradable alpha-2 adrenergic agonist polymeric implants |
| 08/17/2011 | EP2355794A1 Solution of lipophilic substances, especially medicinal solutions |
| 08/17/2011 | EP1976561B1 Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type |
| 08/17/2011 | EP1922087B1 Method for the preparation of polymeric conjugates of doxorubicin with ph-controlled release of the drug |
| 08/17/2011 | EP1625336B1 Use of a layer of solid fuel, method for producing such a layer and associated heating unit |
| 08/17/2011 | EP1599209B1 Inhalation composition |
| 08/17/2011 | EP1575531B1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 08/17/2011 | EP1558273B1 Treatment and prevention of pulmonary conditions |
| 08/17/2011 | EP1404841B1 Cyp1b1 nucleic acids and methods of use |
| 08/17/2011 | EP1328547B1 Identification and modification of immunodominant epitopes in polypeptides |
| 08/17/2011 | CN201930267U 新型蜂药挂片 The new drug coupon bee |
| 08/17/2011 | CN1942197B Use of Lactic acid bacteria in preparing medicine for improved breast milk |
| 08/17/2011 | CN1822765B Delivery of compounds with rehydrated blood cells |
| 08/17/2011 | CN1681845B Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 08/17/2011 | CN102159623A Silica sol material having at least one therapeutically active substance for producing biologically degradable and/or resorbable silica gel materials for human medicine and/or medical technology |
| 08/17/2011 | CN102159251A Method for the preparation of a controlled release system |
| 08/17/2011 | CN102159250A Multi-arm polymeric alkanoate conjugates |
| 08/17/2011 | CN102159249A Pegylated opioids with low potential for abuse |
| 08/17/2011 | CN102159248A Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 08/17/2011 | CN102159247A Drug carriers |
| 08/17/2011 | CN102159246A Method for treating atrophic age related macular degeneration |
| 08/17/2011 | CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
| 08/17/2011 | CN102159220A Thiolated chitosan gel |
| 08/17/2011 | CN102159204A Stable liquid antibody formulation |
| 08/17/2011 | CN102159202A Methods of administering topical antifungal formulations for treatment of fungal infections |
| 08/17/2011 | CN102159192A Preparation method of biodegradable micro-particles containing drugs |
| 08/17/2011 | CN102159191A Medicinal fusidic acid cream made using sodium fusidate and incorporating biopolymer and process for makeing same |
| 08/17/2011 | CN102159189A Nanocarriers for drug delivery |
| 08/17/2011 | CN102159183A Anesthetic composition, formulation and method of use |
| 08/17/2011 | CN102154355A Recombinant immunotoxin CCL25-PE38 gene and preparation method as well as application thereof |
| 08/17/2011 | CN102153761A Modular compound for synthesizing amphiphilic block copolymer and preparation method thereof |
| 08/17/2011 | CN102153657A IL-24-TAT PTD fusion protein and construction method and application thereof |
| 08/17/2011 | CN102153655A Targeted anti-tumor recombinant protein and preparation method thereof |
| 08/17/2011 | CN102153653A Fusion protein of tumor blood vessel targeted polypeptide and tissue factor and preparation method thereof |
| 08/17/2011 | CN102153627A Modifier for gelatinase A inhibitory polypeptide and preparation method thereof |
| 08/17/2011 | CN102153060A Method for preparing hydroxyapatite nano-structure microspheres |
| 08/17/2011 | CN102151547A Method for controlling adsorption, storage and release of guest molecules by using mesoporous material |
| 08/17/2011 | CN102151336A Active targeting drug conveying system for crossing blood brain barrier through mediation of acetylcholine receptor |
| 08/17/2011 | CN102151331A Polysaccharide-protein conjugate vaccines |
| 08/17/2011 | CN102151304A Gastric stasis system of total alkaloids of coptis and evodia rutaecarpa as well as preparation method and application thereof |
| 08/17/2011 | CN102151286A Hydrotalcite tablet and preparation method thereof |
| 08/17/2011 | CN102151285A Neutral calcium supplement preparation |
| 08/17/2011 | CN102151265A Lansoprazole composition for injection |
| 08/17/2011 | CN102151264A Omeprazole sodium composition for injection |
| 08/17/2011 | CN102151257A Busulfan injection and preparation method thereof |
| 08/17/2011 | CN102151253A Nifedipine osmotic pump type controlled release tablet |
| 08/17/2011 | CN102151252A Glipizide osmotic pump type controlled release tablet |
| 08/17/2011 | CN102151249A Medical composition of vinflunine |
| 08/17/2011 | CN102151248A 9-nitrocamptothecin freeze-dried powder injection and preparation method thereof |
| 08/17/2011 | CN102151247A Dry powder formulation comprising racecadotril |
| 08/17/2011 | CN102151246A Novel preparation method of liposome |
| 08/17/2011 | CN102151245A Castor oil micro-emulsion for Nifeviroc anti-cancer medicine and preparation method thereof |
| 08/17/2011 | CN102151244A Sinomenine medicine resin slow-release suspension and preparation method thereof |
| 08/17/2011 | CN102151243A Paclitaxel injection and preparation method thereof |
| 08/17/2011 | CN102151242A In-situ gel slow-release preparation for anti-tuberculosis drugs and preparation method thereof |